Sign up to save your podcasts
Or
Share The Changing Landscape of Clostridioides difficile Infections
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Changing Landscape of Clostridioides difficile Infections
CME credits: 0.25
Valid until: 23-10-2021
Claim your CME credit at https://reachmd.com/programs/cme/changing-landscape-clostridioides-difficile-infections/11932/
Approximately half a million Americans are diagnosed with Clostridioides difficile infections (CDI) each year. About 1 in 5 patients with CDI who are treated and cured will still experience a return of the infection within 2 months. Additionally, approximately 1 in every 10 to 20 patients with CDI will be admitted to the ICU, have a colectomy, or even die from the disease. As it stands currently, physicians do not have the means to identify who will and will not have recurrence, and they also lack the tools needed to identify these patients early in the disease process.
In this discussion, Drs. Kevin Garey and Krishna Rao take a closer look at appropriate, personalized treatment plans for patients with or at risk for recurrent CDI.
View all episodes
By ReachMD
4.3
33 ratings
CME credits: 0.25
Valid until: 23-10-2021
Claim your CME credit at https://reachmd.com/programs/cme/changing-landscape-clostridioides-difficile-infections/11932/
Approximately half a million Americans are diagnosed with Clostridioides difficile infections (CDI) each year. About 1 in 5 patients with CDI who are treated and cured will still experience a return of the infection within 2 months. Additionally, approximately 1 in every 10 to 20 patients with CDI will be admitted to the ICU, have a colectomy, or even die from the disease. As it stands currently, physicians do not have the means to identify who will and will not have recurrence, and they also lack the tools needed to identify these patients early in the disease process.
In this discussion, Drs. Kevin Garey and Krishna Rao take a closer look at appropriate, personalized treatment plans for patients with or at risk for recurrent CDI.